Fidelity Investments
PBLS

Fidelity Investments’s Parabilis Medicines Inc PBLS Stock Holding History

Fidelity Investments’s Portfolio PBLS Stock Details PBLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282M Buy
+10,292,735
New +$284M 0.01% 786

Other funds holding PBLS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM

Fidelity Investments's PBLS Position: Q2 2026 in Review

Fidelity Investments opened a new position in Parabilis Medicines Inc (PBLS) in Q2 2026: 10,292,735 shares worth $282M. The stake represents 0.01% of the portfolio and ranks #786 among its holdings.

80 funds tracked by Wall St. Rank hold PBLS as of Q2 2026.

  • Fidelity Investments held 10,292,735 shares of Parabilis Medicines Inc worth $282M as of Q2 2026.
  • Parabilis Medicines Inc was a new Fidelity Investments position in Q2 2026.
  • Parabilis Medicines Inc made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #786 holding.
  • 80 funds tracked by Wall St. Rank held Parabilis Medicines Inc as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.